Genentech, Inc. vs. Design Therapeutics, Inc. – Trademark Opposition TTAB Proceeding 91272599

This Opposition was filed at the USPTO Trademark Trial and Appeal Board (TTAB) on October 28, 2021 and assigned serial number 91272599 by the TTAB.

Defendant:
Design Therapeutics, Inc. represented by DALE M. CENDALI of KIRKLAND & ELLIS LLP.
Trademark Information: GENETAC – US Trademark Serial Number 90263391
View Trademark Status at USPTO
View Trademark Documents at USPTO

Plaintiff:
Genentech, Inc. represented by JOYCE LIOU of MORRISON & FOERSTER LLP.
Trademark Information: GENENTECH BIOONCOLOGY – US Trademark Serial Number 76501002
View Trademark Status at USPTO
View Trademark Documents at USPTO

Prosecution History:
October 28, 2021 – FILED AND FEE
October 28, 2021 – NOTICE AND TRIAL DATES SENT; ANSWER DUE:
October 28, 2021 – INSTITUTED
November 08, 2021 – D CHANGE OF CORRESP ADDRESS
December 07, 2021 – ANSWER
December 21, 2021 – P APPEARANCE / POWER OF ATTORNEY
January 03, 2022 – D MOT FOR EXT W/ CONSENT
January 18, 2022 – EXTENSION OF TIME GRANTED
February 11, 2022 – P MOT TO AMEND PLEADING/AMENDED PLEADING
February 28, 2022 – D OPP/RESP TO MOTION
March 17, 2022 – RESPONSE DUE 30 DAYS (DUE DATE)
April 14, 2022 – P MOT FOR EXT W/ CONSENT
April 14, 2022 – EXTENSION OF TIME GRANTED
May 16, 2022 – D MOT FOR EXT W/ CONSENT
May 16, 2022 – EXTENSION OF TIME GRANTED
June 15, 2022 – D MOT FOR EXT W/ CONSENT
June 15, 2022 – EXTENSION OF TIME GRANTED
July 11, 2022 – D MOT FOR EXT W/ CONSENT
July 11, 2022 – EXTENSION OF TIME GRANTED
August 15, 2022 – D MOT FOR EXT W/ CONSENT
August 15, 2022 – EXTENSION OF TIME GRANTED
September 13, 2022 – D MOT FOR EXT W/ CONSENT
September 13, 2022 – EXTENSION OF TIME GRANTED
October 12, 2022 – D MOT FOR EXT W/ CONSENT
View this TTAB Proceeding at USPTO

About Select IP
Select IP Law Corporation monitors TTAB proceedings that have been instituted. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.

Leave a Reply

Your email address will not be published. Required fields are marked *